Globally, an estimated 71 million people suffer from chronic liver disease or cirrhosis. The combined diagnoses of chronic liver disease, cirrhosis, viral hepatitis, and liver cancer make liver disease one of the leading causes of death.
Combination antiviral therapy is prescribed for people who have ongoing (chronic) hepatitis C infection. It may be given to people who have never had treatment or when the first set of medicines has failed to treat the infection.
Why should people take antiviral medications for hepatitis C?
The purpose of taking antiviral medications for hepatitis C is to:
- 1. remove (or clear) all the hepatitis C virus from your body
- 2. stop or slow down the damage to your liver
- 3. reduce the risk of developing cirrhosis (advanced scarring of the liver)
- 4. reduce the risk of developing liver cancer (hepatocellular carcinoma)
- 5. reduce the risk of liver failure and the need for a liver transplant
Treatment for chronic hepatitis C infection
Most people diagnosed with chronic hepatitis C infection need treatment for the rest of their lives. Treatment helps reduce the risk of liver disease and prevents you from passing the infection to others. Medicines for hepatitis may include:
- 1. Natdac 60 mg Daclatasvir Tablets
- 2. Hepcinat 400 mg Sofosbuvir Tablets
- 3. Hepcinat LP Ledipasvir Sofosbuvir Tablets
- 4. DaclaHep 60mg Daclatasvir Tablets
- 5. MyHep-LVIR Ledipasvir Sofosbuvir Tablets
- 6. MyHep 400mg Sofosbuvir Tablets
- 7. Velpanat Velpatasvir and Sofosbuvir Tablets